Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms
Chien-Chung Chang1, Shawn P Murphy, Soldano Ferrone
1Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Abstract:
The potential role of human leukocyte antigen G (HLA-G) in tumor immune escape has stimulated interest in the analysis of the expression of this molecule in malignant cells. In melanoma approximately 30% and less than 1% of surgically-removed lesions and cultured cell lines, respectively, have been found to express HLA-G protein. The reason for the marked difference in HLA-G expression frequency is unknown. Here we discuss the potential role of HLA-G detection methodology, stress factors in the tumor microenvironment, and epigenetic changes during tumor progression in the differential in vivo and in vitro HLA-G expression in melanoma cells. We propose a model that may account for the preferential in vivo HLA-G expression in melanoma cells. If proven correct, this model represents a useful background to investigate the mechanisms regulating HLA-G expression in melanoma cells and to devise strategies to counteract HLA-G expression in patients with melanoma.
Insights
Human leukocyte antigen G (HLA-G) plays a role in tumor immune escape. This study explores why HLA-G is more frequently detected in melanoma tumors than in cell cultures, proposing a model for its preferential in vivo expression.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Human Leukocyte Antigen G (HLA-G) is implicated in tumor immune escape.
- Melanoma exhibits differential HLA-G protein expression between in vivo lesions (approx. 30%) and in vitro cell lines (<1%).
- The discrepancy in HLA-G expression frequency between in vivo and in vitro melanoma settings remains unexplained.
Purpose of the Study:
- To investigate the reasons behind the differential expression of HLA-G in melanoma cells.
- To explore the influence of detection methodology, tumor microenvironment stress factors, and epigenetic changes on HLA-G expression.
- To propose a model explaining preferential in vivo HLA-G expression in melanoma.
Main Methods:
- Review and discussion of potential factors influencing HLA-G detection and expression.
- Analysis of tumor microenvironment stress factors.
- Consideration of epigenetic modifications during melanoma progression.
Main Results:
- A significant difference in HLA-G protein expression is observed between surgically-removed melanoma lesions and cultured melanoma cell lines.
- Potential contributing factors to this difference include detection methods, tumor microenvironment conditions, and epigenetic alterations.
- A model is proposed to explain the higher prevalence of HLA-G expression in vivo.
Conclusions:
- The proposed model offers a framework for understanding the regulation of HLA-G expression in melanoma.
- Further investigation into this model could elucidate mechanisms controlling HLA-G expression in melanoma cells.
- This research may inform strategies to modulate HLA-G expression in melanoma patients.
